185 related articles for article (PubMed ID: 30818176)
1. Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.
Iqbal Z; Morahan G; Arooj M; Sobolev AN; Hameed S
Eur J Med Chem; 2019 Apr; 168():154-175. PubMed ID: 30818176
[TBL] [Abstract][Full Text] [Related]
2. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
Malamas MS; Hohman TC; Millen J
J Med Chem; 1994 Jun; 37(13):2043-58. PubMed ID: 8027986
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Lim SS; Jung SH; Ji J; Shin KH; Keum SR
J Pharm Pharmacol; 2001 May; 53(5):653-68. PubMed ID: 11370705
[TBL] [Abstract][Full Text] [Related]
4. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of aldose reductase by dietary antioxidant curcumin: mechanism of inhibition, specificity and significance.
Muthenna P; Suryanarayana P; Gunda SK; Petrash JM; Reddy GB
FEBS Lett; 2009 Nov; 583(22):3637-42. PubMed ID: 19850041
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationship of spirosuccinimide type aldose reductase inhibitors diminishing sorbitol accumulation in vivo.
Ko K; Won H; Won Y
Bioorg Med Chem; 2006 May; 14(9):3090-7. PubMed ID: 16412651
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and aldose reductase inhibitory activity of 2-substituted 6-fluoro-2,3-dihydrospiro[4H-1-benzopyran-4,4'-imidazolidine]-2',5'-dio nes.
Unno R; Yamaguchi T; Usui T; Kakigami T; Fukushima M; Mizuno K; Baba Y; Kurono M
Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1474-8. PubMed ID: 7923471
[TBL] [Abstract][Full Text] [Related]
8. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
Chen H; Zhang X; Zhang X; Fan Z; Liu W; Lei Y; Zhu C; Ma B
Bioorg Med Chem; 2020 Oct; 28(20):115699. PubMed ID: 33069078
[TBL] [Abstract][Full Text] [Related]
9. Effects of two aldose reductase inhibitors upon sorbitol output, D-glucose metabolism and insulin release in islets from normal and hereditarily diabetic rats.
Flores LE; Gagliardino JJ; Sener A; Malaisse WJ
Pharmacol Res; 1998 Jun; 37(6):493-6. PubMed ID: 9695123
[TBL] [Abstract][Full Text] [Related]
10. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
Zhu S; Zhang S; Hao X; Qin X; Parveen S; Yang S; Ma B; Zhu C
J Enzyme Inhib Med Chem; 2016; 31(sup1):126-130. PubMed ID: 27153454
[TBL] [Abstract][Full Text] [Related]
11. Spiro hydantoin aldose reductase inhibitors.
Sarges R; Schnur RC; Belletire JL; Peterson MJ
J Med Chem; 1988 Jan; 31(1):230-43. PubMed ID: 3121857
[TBL] [Abstract][Full Text] [Related]
12. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
Ishibashi Y; Matsui T; Matsumoto T; Kato H; Yamagishi S
Diab Vasc Dis Res; 2016 Jul; 13(4):312-5. PubMed ID: 27190083
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes.
Sobajima H; Aoki T; Sassa H; Suzuki T; Taniko K; Makino M; Mizuno K; Suzuki T
Pharmacology; 2001 May; 62(4):193-9. PubMed ID: 11359994
[TBL] [Abstract][Full Text] [Related]
14. Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners.
Negoro T; Murata M; Ueda S; Fujitani B; Ono Y; Kuromiya A; Komiya M; Suzuki K; Matsumoto J
J Med Chem; 1998 Oct; 41(21):4118-29. PubMed ID: 9767647
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5'-imidazolidine]-2',4'-diones.
Iqbal Z; Hameed S; Ali S; Tehseen Y; Shahid M; Iqbal J
Eur J Med Chem; 2015 Jun; 98():127-38. PubMed ID: 26005026
[TBL] [Abstract][Full Text] [Related]
16. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
17. Potential aldose reductase inhibitors: 1,2,4-triazolidine-3,5-diones and 2-(3,4,5-trimethoxybenzoyl)-4,4-diethyl-3,5-isoxazolidinedione .
Hall IH; Izydore RA; Simlot R; Wong OT
Experientia; 1992 Apr; 48(4):383-6. PubMed ID: 1582496
[TBL] [Abstract][Full Text] [Related]
18. In vitro aldose reductase inhibitory activity of some flavonyl-2,4-thiazolidinediones.
Daş-Evcimen N; Bozdağ-Dündar O; Sarikaya M; Ertan R
J Enzyme Inhib Med Chem; 2008 Jun; 23(3):297-301. PubMed ID: 18569331
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new aldose reductase inhibitor on various tissues in vitro.
Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
